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Mannose-functionalized "pathogen-like" polyanhydride nanoparticles
target C-type lectin receptors on dendritic cells
Abstract
Targeting pathogen recognition receptors on dendritic cells (DCs) offers the advantage of triggering specific
signaling pathways to induce a tailored and robust immune response. In this work, we describe a novel
approach to targeted antigen delivery by decorating the surface of polyanhydride nanoparticles with specific
carbohydrates to provide "pathogen-like" properties that ensure nanoparticles engage C-type lectin receptors
on DCs. The surface of polyanhydride nanoparticles was functionalized by covalent linkage of dimannose and
lactose residues using an amine-carboxylic acid coupling reaction. Coculture of functionalized nanoparticles
with bone marrow-derived DCs significantly increased cell surface expression of MHC II, the T cell
costimulatory molecules CD86 and CD40, the C-type lectin receptor CIRE and the mannose receptor
CD206 over the nonfunctionalized nanoparticles. Both nonfunctionalized and functionalized nanoparticles
were efficiently internalized by DCs, indicating that internalization of functionalized nanoparticles was
necessary but not sufficient to activate DCs. Blocking the mannose and CIRE receptors prior to the addition
of functionalized nanoparticles to the culture inhibited the increased surface expression of MHC II, CD40
and CD86. Together, these data indicate that engagement of CIRE and the mannose receptor is a key
mechanism by which functionalized nanoparticles activate DCs. These studies provide valuable insights into
the rational design of targeted nanovaccine platforms to induce robust immune responses and improve
vaccine efficacy.
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’ INTRODUCTION
The use of vaccine adjuvants to activate the innate immune
system is crucial to vaccine eﬀectiveness.1 Adjuvants can be used
to enhance the eﬃcacy of single dose vaccines and reduce the
required antigen dose. The use of biodegradable polymer nano-
particles as vaccine delivery vehicles allows for eﬀective delivery
of payloads by parental ormucosal administration by protecting the
antigen from harsh physiological conditions and enabling trans-
port across biological barriers (e.g., mucus membranes).2
Polyanhydride nanoparticles have shown excellent potential as
vaccine carriers.36 Encapsulation of protein antigens into poly-
anhydride particles stabilizes them and provides sustained aznti-
gen release;4,7 these particles also enhance the immune response
by acting as an adjuvant.3
Dendritic cells (DCs) are antigen presenting cells (APCs) that
play a major role in connecting the innate and adaptive immune
systems, a key step to inducing protective immunity.8 DCs can
sense and internalize antigen by a variety of mechanisms that
trigger DC maturation and direct further interactions with other
immune cells, including naive T cells.1,9,10 Pattern recognition
receptors (PRRs) on DCs detect the presence of a potential
threat by interacting with pathogen-associated molecular pat-
terns (PAMPs).10,11 In particular, C-type lectin receptors (CLRs)
are PRRs with highly conserved carbohydrate-recognition do-
mains that bind sugar moieties (e.g., mannose, fucose, and glucan)
on the surface of certain pathogens (e.g., Candida albicans,
Mycobacterium tuberculosis, and Mycobacterium leprae) in a
calcium-dependent manner.12,13 Ligand recognition by Toll-like
receptors, a type of PRR, promotes a cascade of intracellular
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ABSTRACT: Targeting pathogen recognition receptors on
dendritic cells (DCs) oﬀers the advantage of triggering speciﬁc
signaling pathways to induce a tailored and robust immune
response. In this work, we describe a novel approach to targeted
antigen delivery by decorating the surface of polyanhydride
nanoparticles with speciﬁc carbohydrates to provide “pathogen-
like” properties that ensure nanoparticles engage C-type lectin
receptors on DCs. The surface of polyanhydride nanoparticles
was functionalized by covalent linkage of dimannose and lactose
residues using an aminecarboxylic acid coupling reaction.
Coculture of functionalized nanoparticles with bone marrow-
derived DCs signiﬁcantly increased cell surface expression of
MHC II, the T cell costimulatory molecules CD86 and CD40,
the C-type lectin receptor CIRE and the mannose receptor
CD206 over the nonfunctionalized nanoparticles. Both non-
functionalized and functionalized nanoparticles were eﬃciently
internalized by DCs, indicating that internalization of function-
alized nanoparticles was necessary but not suﬃcient to activate
DCs. Blocking the mannose and CIRE receptors prior to the
addition of functionalized nanoparticles to the culture inhibited the increased surface expression of MHC II, CD40 and CD86.
Together, these data indicate that engagement of CIRE and the mannose receptor is a key mechanism by which functionalized
nanoparticles activate DCs. These studies provide valuable insights into the rational design of targeted nanovaccine platforms to
induce robust immune responses and improve vaccine eﬃcacy.
KEYWORDS: polyanhydrides, nanoparticles, carbohydrates, dendritic cells, targeting
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signaling events.14 In addition, ligand recognition by CLRs leads
to pathogen internalization via receptor mediated endocytosis
and subsequent degradation and presentation of the pathogen as
antigen to T cells in the context of MHC I or MHC II, or
both.13,15 Engagement of CLR-associated signaling processes can
induce diverse immune responses depending upon the type of
carbohydrate ligand bound, the type of responding APC and the
engagement of other PRRs on the APC.12 Thus, the targeting
to and the activation of signaling pathways associated with CLRs
(e.g., activation of NF-kB signaling pathway) can be a powerful
strategy to tailor the immune response.11,13,14
Previous studies have demonstrated the potential of targeting
CLRs to induce DC maturation and activation; these studies
focused on the use of mannoproteins from pathogens16 or the
conjugation of glycans directly to the antigen.17 Limited studies
have explored the use of carbohydrate-functionalized vaccine
carriers as targeting vehicles, with most studies using antibodies
as ligands.18 This study outlines a novel approach to target the
mannose receptor (CD206) andCIRE (CD209) onmurine DCs
by mimicking carbohydrate moieties found on the surface of
pathogens.19 Polyanhydride nanoparticle surfaces were function-
alized with dimannose in order to study speciﬁc interactions with
both CLRs known to recognize mannose residues.10,13 The poly-
anhydride system used in this study is an amphiphilic copoly-
mer of 1,6-bis(p-carboxyphenoxy)hexane (CPH) and 1,8-bis-
(p-carboxyphenoxy)-3,6-dioxaoctane (CPTEG). The studies
described herein demonstrate that mannose-functionalized poly-
anhydride nanoparticles induce receptor-mediated activation of
DCs that may be exploited to enhance the adjuvanticity of this
targeted delivery platform.
’MATERIALS AND METHODS
Materials. Chemicals needed for monomer synthesis and
polymerization, as well as for nanoparticle fabrication, including
p-carboxybenzoic acid (99+%), and 1-methyl-2-pyrrolidinone,
anhydrous (99+%), were purchased from Aldrich (Milwaukee,
WI); 4-p-hydroxybenzoic acid, 1,6-dibromohexane, 1-methyl-2
pyrrolidinone, and triethylene glycol were purchased from Sigma
Aldrich (St. Louis, MO); 4-p-fluorobenzonitrile was obtained
from Apollo Scientific (Cheshire, U.K.); potassium carbonate,
dimethyl formamide, toluene, sulfuric acid, acetic acid, ace-
tonitrile, acetic anhydride, methylene chloride, pentane, and
petroleum ether were purchased from Fisher Scientific (Fair-
lawn, NJ).
Monomer and Polymer Synthesis. CPTEG:CPH copoly-
mers were synthesized by melt polycondensation as described
previously.20 The chemical structure was characterized with 1H
NMR, and the molecular mass was determined using gel
permeation chromatography (GPC).20
Nanoparticle Fabrication.An antisolvent nanoencapsulation
method recently published by Ulery et al.21 was used to fabricate
nanoparticles based on a 50:50 molar ratio of CPTEG:CPH
copolymers (50:50 CPTEG:CPH). Briefly, polymer was dis-
solved in methylene chloride (15 mg/mL) held at 4 C. The
polymer solution was rapidly poured into a bath of pentane held
at 40 C at an antisolvent to solvent ratio of 1:150. Particles
were collected by filtration and dried under vacuum for 2 h. For
fluorescence microscopy studies, FITCdextran (1% (w/w))
was suspended and homogenized by sonication in the polymer
solution prior to precipitation.
Nanoparticle Surface Functionalization. Synthesis of Car-
boxylated Lactose and Dimannose. β-1-O-Allylated lactose22 was
prepared through mercury(II)-catalyzed allylation23 of penta-
O-acetyl-lactosyl bromide. As expected, use of excess amounts
of NaIO4 (8 equiv) under ruthenium-catalyzed Sharpless con-
ditions24,25 produced the desired acid in 91% yield. Subsequent
deacetylation under mild conditions using K2CO3 provided the
desired fully deprotected disaccharide (Figure 1A).
To obtain the dimannoside, the iterative synthesis of linear α-
1,2-linked dimannose with a ﬂuorous allyl group using ﬂuorous-
solid phase extraction (FSPE) served as the model.2628 Carbox-
ylmethyl- dimannose was obtained by ozonolysis of the alkene,29
followed by further oxidation with Jones reagent.26 Global
deprotection under Birch reduction30 furnished the fully depro-
tected α-1,2-linked dimannose (Figure 1B).
Surface Functionalization. Lactose and dimannose were
conjugated on the surface of polyanhydride nanoparticles by an
aminecarboxylic acid coupling reaction.28,30,31 Lactose, a neu-
tral sugar with the same molecular weight as dimannose, was
chosen as a control sugar because of its different stereochemical
configuration compared to dimannoside. Particles with glycolic
Figure 1. Schematic representation of the synthesis of (A) carboxy-functionalized lactose and (B) carboxy-functionalized dimannose.
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acid groups on the surface (linker groups) and nonfunctionalized
(NF) particles were used as controls. An average concentration
of 9.6  104 mmol of COOH/mg of NF nanoparticles was
calculated by a theoretical approach using the end groups
obtained from 1H NMR spectra and by deconvolution analysis
of the C1s high-resolution spectra obtained from X-ray photo-
electron spectroscopy (XPS). The conjugation reaction was
performed by incubating a nanoparticle suspension (100 mg/mL)
with 10 equiv of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide
hydrochloride (EDC), 12 equiv of N-hydroxysuccinimide (NHS),
and 10 equiv of ethylene diamine in distilled water. This first
incubation was carried out at room temperature for 12 h at a
constant agitation of 350 rpm. After the incubation period,
particles were centrifuged at 10,000 rpm for 10 min and the
supernatant was removed. A new incubation was performed with
12 equiv of EDC, 12 equiv of NHS and 10 equiv of the corre-
sponding saccharide (i.e., lactose or dimannose) in distilled
water, using constant agitation at 350 rpm for 12 h at room tem-
perature. Particles were sonicated before and after each incuba-
tion period to break aggregates. After the reaction was com-
pleted, nanoparticles were collected by centrifugation (10,000 rpm,
10 min) and dried under vacuum overnight.
Characterization of Functionalized Nanoparticles. The
morphology and size of functionalized and nonfunctionalized
nanoparticles were characterized by scanning electron micro-
scopy (SEM, JEOL 840A, JEOL Ltd., Tokyo, Japan) and quasi-
elastic light scattering (QELS, Zetasizer Nano, Malvern Instru-
ments Ltd., Worchester, U.K.), respectively. For SEM, samples
were vacuum-dried and coated with gold before imaging with the
electron microscope. The nanoparticles were suspended in cold
water and sonicated for one minute before QELS readings were
performed. QELS was also used to determine the ζ-potential of
nonfunctionalized and functionalized nanoparticles in order to
determine the presence of the disaccharides. XPS (PHI 5500
Multitechnique system, Physical Electronics, Inc., Chanhassen,
MN) was used to determine the presence of lactose and dimannose
on the surface of polyanhydride nanoparticles. Binding energies
were referenced to the aliphatic hydrocarbon peak at 285.0 eV.32
High-resolution C1s peaks were collected and fitted using
CasaXPS software (RBS Instruments, Bend, OR). Finally, a mod-
ified and optimized high throughput version of a phenolsulfuric
acid assay33 was used to quantify the amount of sugar attached to
the nanoparticles. The modified assay was performed directly in
96-well plates, and the incubation time was increased to 30 min
to allow for equal reduction of the different sugars used to link to
the nanoparticles. Nonfunctionalized nanoparticles were used as
controls to account for polymer interference with the assay. A
microplate reader was used to obtain the absorbance of standards
and unknown samples using a wavelength of 490 nm. The total
amount of sugar (μg/mg) was calculated by normalization with
the nanoparticle mass.
In Vitro DC Uptake and Activation. Mice. C57BL/6 (B6)
mice were purchased from Harlan SpragueDawley (Indianapolis,
IN). All mice were housed under specific pathogen-free conditions
where all bedding, caging, and feed were sterilized prior to use. All
animal procedures were conducted with the approval of the Iowa
State University Institutional Animal Care and Use Committee.
DC Culture and Stimulation. Dendritic cells were derived
from the bone marrow precursor cells recovered from the femurs
and tibias of B6 mice according to a previously published
protocol.34,35 DCs were >90% positive for DC marker CD11c.
For flow analysis, nonstimulated (NS) DCs and Escherichia coli
lipopolysaccharide (LPS) (200 ng/mL) (Sigma Aldrich, St.
Louis, MO) treated DCs were used as negative and positive
controls, respectively. On day 9 of the culture, nonfunctionalized
or functionalized nanoparticles were incubated with DCs for 48 h
at a concentration of 0.125 mg/mL, a concentration chosen
based on previously published studies.35 In order to investigate
the role of mannose receptor engagement in DC activation
by dimannose-functionalized polyanhydride nanoparticles, QJ;
DCs were incubated with anti-CD206 (Clone 310301, R&D
Systems, Minneapolis, MN) and/or anti-CD209 (Clone LWC06,
eBioscience, San Diego, CA) antibodies either individually or in
combination at a final concentration of 10 μg/mL for 15 min
at room temperature prior to addition of stimulants. Pre-
incubation with anti-CD206 and/or anti-CD209 blocked the
cross-linking of the mannose and/or CIRE receptors by sugar-
functionalized nanoparticles. This treatment tested the hy-
pothesis that functionalized nanoparticles enhance DC acti-
vation via increased mannose and/or CIRE receptor-mediated
endocytosis.
Flow Cytometric Analysis. Flow cytometric analysis of surface
molecule expression was performed as previously described.34
Additional antibodies used in this study include FITC anti-
mouse CD206 (MMR, clone MR5D3) and the isotype-specific
control antibody FITC rat IgG2a k (clone RTK2748) purchased
from BioLegend (San Diego, CA), and biotin anti-mouse CD209
(CIRE, clone 5H10) purchased from eBioscience (San Diego,
CA). As noted, the two antibodies used for FACS analysis are
different from the antibodies used to block CLRs, thus prevent-
ing false negatives due to unavailable binding sites following
treatment with the blocking antibody. Samples were acquired on
a Becton-Dickinson FACSCanto flow cytometer (San Jose, CA)
and the data analyzed using FlowJo (TreeStar Inc., Ashland,
OR). Percentage of cells expressing each cell surface marker were
obtained by quantifying the peak shift from their respective
isotype controls, and the intensity of the expression was reported
as mean fluorescence intensity (MFI).
Cytokine Assays. After stimulation for 48 h with nonfunctio-
nalized or functionalized nanoparticles, cell-free supernatants
were assayed for IL-1β, IL-10, TNF-α, IL-6, and IL-12p40 using a
multiplex cytokine assay in conjunction with a Luminex 100
System (Flowmetrics, Austin, TX) as described elsewhere.34,35
Fluorescence Microscopy Analysis of Nanoparticle Up-
take by DCs. To visualize nanoparticle interactions with DCs, a
previously described experimental protocol for coincubation,
immunofluorescence preparation and microscopic observation
was followed.21 In these experiments, an equivalent amount
(200 μg/mL) of either nonfunctionalized or functionalized 1%
FITCdextran loaded nanoparticles were incubated with DCs
and then washed repeatedly three times with pH 7.4 PBS to
remove extracellular and nonadherent particles. DCs coincu-
bated with nanoparticles for 30 min were fixed and analyzed 2 h
post uptake. At the indicated times, cultures were fixed for 20min
with 4% paraformaldehyde in pH 7.4 PBS, washed and incubated
with 5 μg/mL tetramethylrhodamine-wheat germ agglutinin
(WGA) for 10 min at 37 C. Stained and washed coverslips
were mounted on glass slides using Pro-Long w/DAPI mountant
(Invitrogen, Carlsbad, CA). Epifluorescence microscopy was per-
formed using an Olympus IX-71 inverted microscope with blue,
green, and red filter sets with a cooled CCD camera. Final image
preparation and morphometric analysis was performed as de-
scribed previously utilizing threshholding and particle counting
algorithms of ImageJ v1.36b software (NIH, Bethesda, MD).21
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Binary data was extracted from grayscale images collected from
the FITC bandpass filter set using equivalent exposure settings
from fixed samples of DCs various nanoparticle modifications.
For each sample, images from 5 fields of view (FOV) were
collected and compiled with all grayscale images, including the 5
FOV from the various nanoparticle formulations. The compiled
image set was then batch treated for background subtraction and
thresholding using parameters set according to negative (no
particle) control cultures that were performed in parallel for each
experiment and time point. Results presented are compiled from
three separate biological replicates.
Statistical Analysis.The statistical software JMP7 was used to
analyze the cell surfacemarker, cytokine, and internalization data.
One-way ANOVA and Tukey’s HSD were used to determine
statistical significance among treatments, and p-values <0.05
were considered significant.
’RESULTS
Polymer Synthesis. A 50:50 molar ratio copolymer of
CPTEG and CPH was synthesized as previously described.20
This formulation was chosen for these studies because previous
studies have shown that it preserves protein structure and
antigenicity in addition to exhibiting adjuvant properties.4,5,7,34
1H NMR spectroscopy was used to characterize the polymer
structure, and the spectra were consistent with previously pub-
lished data.20 The synthesized 50:50 CPTEG:CPH copolymer
had aMw of 8,500 g/mol with a polydispersity index of 1.7. These
values are consistent with previous work.7,20
Characterization of Functionalized Nanoparticles. Particle
morphology and size of both nonfunctionalized and functional-
ized-nanoparticles were analyzed by SEM (data not shown).
Some aggregation was observed after surface functionalization,
which was attributed to the reaction conditions. The aggregation
was disrupted by sonicating the nanoparticles before use, as
indicated by the size distribution profiles of the sonicated
nanoparticles obtained by QELS (Table 1). No significant
differences were observed between the size of the functionalized
and the nonfunctionalized nanoparticles.
Measurements of ζ-potential using QELS were employed to
characterize the nanoparticle surface functionalization (Table 1).
The nonfunctionalized nanoparticles exhibited a ζ-potential of
20 mV. In contrast, the various functionalized nanoparticles
resulted in a positively charged ζ-potential (ranging from 20 to
26 mV). The positive charge observed after functionalization is
attributed to the presence of the diamine linker on the surface of
the particles; this was corroborated by analyzing the ζ-potential
of nanoparticles that were only reacted with the ethylene diamine
linker but without glycolic acid or sugar. This control showed a
slightly more positive ζ-potential in comparison to the linker and
sugar modiﬁed particles. As expected, the reaction yield of sugar
attachment to the linker is not 100%. Since the dimannoside is a
neutral sugar, the free amine groups present on the surface of the
particles are responsible for the positive charge observed.
The functionalized nanoparticles were characterized using
XPS36 to quantitatively determine successful linker and sugar
conjugation to the nanoparticle surface. Table 2 shows the
surface elemental atomic percentages and elemental ratios of
nonfunctionalized and functionalized nanoparticles. Clear diﬀer-
ences in the N/C ratio were observed, showing a signiﬁcant
increase in nitrogen content (i.e., 0.01 in the nonfunctionalized
particles to almost 0.07 in the functionalized particles). This
increase in nitrogen content is directly related to the presence of
the amine linker. The presence of nitrogen groups on the surface
makes the surface composition of these particles similar to that of
pathogens, which are known to have a high content of amine-
containing compounds.37
High-resolution C1s spectra were ﬁtted with four main
components according to their characteristic binding energies
representing aliphatic hydrocarbon at 285.0 eV (C1), ether and
amine groups at 286.5 eV (C2), carbonyl and amide groups at
288.2 eV (C3), and ester and carboxylic acid groups at 289.1 eV
(C4).32 Analysis of C1s spectra allows for more direct compar-
ison of sugar attachment based on increases in the ether and
amine groups (C2). Ether groups are characteristic of carbohy-
drate structures while the amine groups are indicative of the
presence of the amine linker used for surface modiﬁcation. Table 3
shows the average percentage areas obtained from high-resolu-
tion C1s ﬁtted spectra. These data indicate a clear increase in the
C2 component in the functionalized-nanoparticle groups, espe-
cially those functionalized with lactose and dimannose. The C2
component percentage for the nonfunctionalized 50:50 CPTEG:
CPH nanoparticles is ∼22%, while that of the sugar-functional-
ized nanoparticles is∼30%. It is known that the outer surface of
bacterial pathogens is composed of various constituents bearing
amine and hydroxyl groups (e.g., peptidoglycan, lipopolysacchar-
ide, lipoproteins, and ﬂagella).37 Analysis of C1s (Table 3) and
Table 1. Nanoparticle Characterizationa
nanoparticle type
average particle
diameter (nm)
av particle
ζ-potential (mV)
sugar density
(μg/mg of particle)
nonfunctionalized 162( 43 20( 0.6
linker 231( 52 21( 1.5
lactose 266( 44 26( 2.4 10.9( 6.8
dimannose 278( 32 28( 3.2 12.4( 5.5
aNonfunctionalized and functionalized nanoparticles were character-
ized by QELS and zeta potential measurements. Particle size data
represent the mean value ( standard deviation (SD) of dynamic light
scattering data collected in three independent experiments. Zeta poten-
tial data represent the mean value( SD of three independent readings.
Change in zeta potential clearly indicates that sugars were eﬃciently
conjugated to the 50:50 CPTEG:CPH nanoparticles' surface. Sugar
density on nanoparticles' surface was determined by a colorimetric
phenolsulfuric acid assay. Amount of sugar was determined relative to
standard curves; data is presented as mean ( SD of four independent
experiments.
Table 2. X-ray Photoelectron Spectroscopy (XPS) Analysis of
Atomic Percentages and Ratios of Elements Present on
Nonfunctionalized and Functionalized 50:50 CPTEG:CPH
Nanoparticlesa
nanoparticle type % Cb % Nb % Ob O/Cc N/Cc
nonfunctionalized 74.9( 1.5 1.2( 0.1 23.9( 2.3 0.320 0.016
linker 65.5( 0.9 4.4( 0.5 18.1( 1.9 0.276 0.067
lactose 76.3( 2.1 5.1 ( 0.4 20.9( 1.1 0.274 0.067
dimannose 73.9 ( 1.1 5.3( 0.7 23.3( 1.5 0.315 0.072
aAn increase in the nitrogen content of functionalized nanoparticles
correlates with the presence of the amine linker used in the amine
carboxylic acid reaction. b Data reported as mean ( standard
deviation of four independent experiments performed in triplicate.
c Ratio of the two elements as indicated.
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O1s (data not shown) spectra of functionalized nanoparticles
showed a clear increase of amine, ether, and hydroxyl groups,
resulting in a surface composition that is similar to that of
pathogens.37 The total amount of sugar attached to the nano-
particle surface was quantiﬁed by the phenolsulfuric acid assay.
The results showed that similar amounts (12.6 ( 6.4 μg/mg of
particle) of lactose and dimannose were attached to the 50:50
CPTEG:CPH nanoparticles (Table 1).
Dimannose-Functionalized Nanoparticles Enhanced DC
Expression of MHC II, Costimulatory Molecules and CLRs.
Flow cytometry was used to determine if functionalized nano-
particles enhanced the activation status of DCs. In general, the
results indicate that dimannose-functionalized nanoparticles sig-
nificantly enhanced the expression of key surface markers that are
associated with DC maturation and antigen presentation (i.e.,
MHC II, CD86, and CD40) and concomitantly increased the
surface expression of CLRs (i.e., CD206 and CIRE) as compared
to nonfunctionalized nanoparticles (Figure 2). Another interest-
ing observation from these studies is that the dimannose-
functionalized nanoparticles induced higher expression of both
CD206 and CIRE as compared to lactose-functionalized parti-
cles, confirming the specificity of both CIRE and CD206 for
mannose residues as observed previously.13
Soluble lactose and dimannose and nonfunctionalized nano-
particles plus soluble sugar were used as controls to probe the
beneﬁt of the covalent linkage of the sugars to the nanoparticle
surface. The addition of soluble sugars (i.e., lactose and dimannose)
to cultures of DCs with nonfunctionalized nanoparticles did not
signiﬁcantly change cell surface marker expression from levels
induced by the nonfunctionalized nanoparticles alone (Supple-
mental Figure 1 in the Supporting Information).
Stimulation with Functionalized Nanoparticles Enhanced
Proinflammatory Cytokine Secretion.Although stimulation of
DCs with either nonfunctionalized or functionalized nanoparti-
cles modestly increased the secretion of IL-6 in comparison to
the nonstimulated controls, the greatest amounts of IL-6 were
produced by DCs stimulated with linker-modified nanoparticles
(black bars in Figure 3). Elevated levels of TNF-α were secreted
(gray bars in Figure 3) upon stimulation with the linker-
functionalized particles. Neither IL-10 nor IL-1β was detected
in the culture supernatants (data not shown). This observation is
consistent with previously published work with other polyanhy-
dride chemistries35 and different particle sizes.34 The level of
IL-12p40 secreted into the culture medium by DCs stimulated
with either nonfunctionalized or functionalized nanoparticles
was not statistically different from the nonstimulated controls
(data not shown).
Both Nonfunctionalized and Functionalized Nanoparti-
cles Were Efficiently Internalized by DCs. Microscopic ana-
lyses were performed to determine if the enhanced activation of
DCs by functionalized nanoparticles was associated with en-
hanced internalization. Interestingly, all the functionalized na-
noparticle groups were efficiently internalized following 30 min
of coincubation withDCs (Figure 4A). These qualitative findings
were corroborated by morphometric analysis of the epifluores-
cent images of the FITC-loaded nanoparticles, which is pre-
sented as the total area (μm2) of internalized nanoparticles. This
metric allowed us to perform biologically relavent comparisons
among all treatments. The morphometric analysis revealed that
higher amounts of functionalized nanoparticles were internalized
by DCs when compared to nonfunctionalized nanoparticles
(Figure 4B).
Mannose Receptor-Mediated Activation of DCs by Di-
mannose-Functionalized Nanoparticles. To test the specifi-
city of the dimannose functionalization for binding to CLRs,
monoclonal antibodies were used to inhibit activation of the
mannose receptor and CIRE on DCs stimulated with nonfunc-
tionalized and dimannose-functionalized nanoparticles (Figure 5).
For all the surfacemarkers evaluated (i.e., MHC II, CD40, CD86,
CD209, and CD206), the mean fluorescence intensity (MFI)
values for the nonstimulated DCs did not change over that of the
controls when the monoclonal antibodies against the CLRs were
added, indicating that no additional stimulation was provided by
the antibodies used as blocking agents. After blocking with anti-
CD209 or anti-CD206, a reduction in the expression of CIRE
and CD206, respectively, was observed after stimulation with
dimannose-functionalized nanoparticles (as shown in Figure 5D
and 5E). This result demonstrates that the use of specific mono-
clonal antibodies can block the upregulation of the mannose and
CIRE receptors induced by dimannose-functionalized particles.
Furthermore, when the anti-CD206 monoclonal antibody was
used, the increased surface expression of MHC II, CD40, and
CD86 was inhibited (Figures 5A, 5B and 5C). This outcome
demonstrates that mannose receptor engagement by the func-
tionalized nanoparticles plays a critical role in their adjuvant
effect. In these experiments, the linker and lactose-functionalized
particles were also added to separate DC cultures to control for
the specificity of the blocking antibodies. After pretreatment with
the anti-CD206 monoclonal antibody, there was no significant
inhibition in the expression of MHC II, CD40, and CD86
(Supplemental Figure 2 in the Supporting Information), further
corroborating the specificity of the mannose receptor mediating
DC activation by the dimannose-functionalized nanoparticles.
’DISCUSSION
Engineering nanoparticles that are targeted to speciﬁc recep-
tors on APCs oﬀers a novel approach for the rational design of
eﬀective vaccine adjuvants. The covalent linkage of speciﬁc
carbohydrates to the surface of nanoparticles allows for the
targeting of CLRs and activation of complex signaling pathways
including crosstalk with other PRRs (e.g., TLRs and Fc receptors)
that can direct the immune response. The data presented herein
demonstrate the design and fabrication of novel dimannose-
functionalized polyanhydride nanoparticles that possess charac-
teristically similar chemical compositions as that of pathogen
surfaces. These “pathogen-like” nanoparticles were eﬃciently
Table 3. Average Percentage Areas of Aliphatic Hydrocarbon
(C1), Ether and Amine Groups (C2), Carbonyl and Amide
Groups (C3), and Ester and Carboxylic Acid Groups (C4)a
percentage area of C1s componentsb
nanoparticle type C1 C2 C3 C4
nonfunctionalized 59.7( 1.2 22.3( 0.7 8.7( 0.6 1.4( 0.1
linker 58.3 ( 1.7 26.6( 0.7 7.1( 0.3 0.1( 0.2
lactose 58.2( 0.8 30.1( 1.2 6.6( 0.6 0.6( 0.1
dimannose 58.1( 1.9 29.6( 1.0 6.9( 0.5 0.4( 0.1
aObtained from XPS high-resolution C1s ﬁtted spectra. Increased
surface presence of ether, amine and hydroxyl groups corroborated
nanoparticle functionalization. bData reported as mean ( standard
deviation of four independent experiments performed in triplicate.
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internalized by DCs (Figure 4) and concomitantly activated DCs
(Figures 2 and 3) in vitro by speciﬁc interactions with the
mannose receptor (Figure 5).
All the particles (i.e., nonfunctionalized and linker, lactose, and
dimannose-functionalized) enhanced the expression of MHC II,
CD40, and CIRE (Figures 2A, 2C and 2D) when compared to
nonstimulated DCs. While nonfunctionalized 50:50 CPTEG:
CPH nanoparticles demonstrated moderate DC activation,
dimannose functionalization of the nanoparticles induced greater
expression of MHC II, CD40, and CD86. MHC II, CD40, and
CD86 play an important role in the induction of adaptive
immunity through activation of CD4+ T cells, and it would be
beneﬁcial for an eﬀective adjuvant to enhance the expression of
MHC II and costimulatory molecules.1,9,34
CIRE and the mannose receptor play an important role in
antigen uptake, as well as in DC migration and initial interaction
with T cells.911,13 As mentioned before, the activation of CLR-
induced signaling processes can result in the induction of diverse
immune responses.12 As shown in Figures 5D and 5E, by
chemically conjugating dimannose to the surface of polyanhy-
dride nanoparticles, eﬀective cross-linking of CLRs on DCs was
achieved, resulting not only in a higher expression of both CIRE
and CD206 but also in higher expression of other DCmaturation
markers (i.e., MHC II, CD40, and CD86) compared to the
nonfunctionalized particles. High aﬃnity binding of CLRs to
their ligands is known to result in increased expression of the
receptor on the cell surface.38 Additionally, the results presented
in Supplemental Figure 1 in the Supporting Information demon-
strate that the sugars must be covalently attached to the
nanoparticles to enhance the activation of the DCs. Finally, the
data presented in Supplemental Figure 2 in the Supporting
Information further corroborates the binding of the diman-
nose-functionalized nanoparticles to the mannose receptor in
order to enhance the activation of DCs.
The expression of MHC II, CD86 and CD40 is essential for
antigen presentation and activation of naive T cells; however, it is
not suﬃcient to induce an eﬀective T cell response. In the context
of a robust immune response, DCs need to secrete an appropriate
proﬁle of cytokines to enhance CD4+ T cell activation. The data
Figure 2. Dimannose-functionalized nanoparticles enhanced DC expression of MHC II, costimulatory molecules and C-type lectin receptors (CLRs).
After stimulation with either nonfunctionalized (NF) or functionalized nanoparticles for 48 h, DCs were harvested and analyzed by ﬂow cytometry for
surface expression of (A)MHC II, (B) CD86, (C) CD40, (D) CIRE, or (E) CD206. LPS stimulated and nonstimulated cells (NS) were used as positive
and negative controls, respectively. Data are expressed as themean( the SEMof four independent experiments performed in triplicate. * and # represent
groups that are statistically signiﬁcant (p e 0.05) compared to the NS or NF groups, respectively. MFI = mean ﬂuorescence intensity.
Figure 3. Stimulation with functionalized nanoparticles enhanced
secretion of proinﬂammatory cytokines from DCs. After stimulation
with nonfunctionalized (NF) or functionalized nanoparticles for 48 h,
supernatants were harvested and assayed for IL-6 (black bars) and TNF-
α (gray bars). Data is represented as mean concentration of cytokines(
the SEM of four independent experiments performed in triplicate. LPS
was used as a positive control stimulant (>50,000 pg/mL for IL-6 and
6,861 pg/mL for TNF-α), and nonstimulated cells (NS) were used as a
negative control. * and # represent groups that are statistically signiﬁcant
(p e 0.05) compared to the NS or NF groups, respectively.
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presented in Figure 3 demonstrate that DCs secreted IL-6 after
stimulation with both nonfunctionalized and functionalized
nanoparticles. IL-6 is important to both innate and adaptive
immune response, as it contributes to systemic inﬂammation1
and promotes humoral immune responses.39 Linker-functional-
ized nanoparticles also induced the secretion of TNF-α. This
cytokine is important in early DC maturation and further
induction of T cell diﬀerentiation, and, therefore, even small
amounts can inﬂuence the bias and magnitude of an immune
response. Production of these two cytokines by DCs has been
previously associated with CLR-induced signaling events.12,16
The observed enhancement in surface molecule expression
(Figure 2) and IL-6 secretion (Figure 3) byDCs after stimulation
with dimannose-functionalized nanoparticles was hypothesized
to be related to an increase in particle internalization.40 However,
as shown in Figure 4, all functionalized nanoparticles were
eﬃciently internalized by DCs. In particular, both linker and
dimannose-functionalized nanoparticles were present in higher
Figure 4. Both nonfunctionalized and functionalized nanoparticles (green) were eﬃciently internalized by DCs after coincubation for 30 min.
Monolayers incubated for 2 h postinternalization with FITC-loaded nanoparticles were stained with WGA conjugated with tetramethylrhodamine
to delineate the plasma membrane. (A) Epiﬂuorescent microscopy demonstrated that nanoparticle functionalization enhanced internalization
when compared to nonfunctionalized (NF) nanoparticles. Representative epiﬂuorescent images were captured using identical exposure conditions.
(B) Quantitative morphometric analysis measuring nanoparticle uptake per ﬁeld of view (FOV). Data is reported as the total area of ﬂuorescence
detected within each FOV (* represents groups that are statistically signiﬁcant (pe 0.05) compared to the NF group). Images shown are representative
of four ﬁelds of view analyzed for each group and consistently observed over three independent experiments. Scale bar = 20 μm.
1884 dx.doi.org/10.1021/mp200213r |Mol. Pharmaceutics 2011, 8, 1877–1886
Molecular Pharmaceutics ARTICLE
numbers inside the DCs than nonfunctionalized and lactose-
functionalized nanoparticles. These data indicate that particle inter-
nalization is necessary but not suﬃcient for enhanced DC activation.
Previous work from our laboratories has demonstrated enhanced
internalization of soluble antigen bymonocytes when deliveredwith
nonfunctionalized polyanhydride nanoparticles.21 Therefore, the
results presented in Figure 4 suggest that the functionalized nano-
particles would also provide eﬃcient antigen delivery.
The speciﬁc interaction of functionalized nanoparticles with
CLRs documented in this study presents an intriguing opportu-
nity for the rational design of nanovaccines possessing the
capacity to induce diverse immune responses tailored for a target
disease. While the increased activation of DCs with dimannose-
functionalized particles was directly correlated with a receptor
ligand interaction, the enhanced internalization of linker-func-
tionalized nanoparticles represents a nonspeciﬁc interaction that
may be dictated by the positive charge of the functionalized
particles. It is well-known that cationic particles show greater
adhesion with cell membranes41 and, therefore, may be an explana-
tion for the enhanced cellular uptake of the linker-functionalized
nanoparticles observed in this study. In addition, the nonspeciﬁc
interaction due to the linker-functionalized nanoparticles may
closely mimic the interaction between DCs and endogenous
danger signals. Indeed, cellular recognition of endogenous (e.g.,
hyaluronic acid, uric acid crystals) and exogenous (e.g., LPS,
lipoteichoic acid) hydrophobic moieties is an important compo-
nent of the danger hypothesis describing activation of innate
immune responses.42,43 Nonfunctionalized polyanhydride nano-
particles present a hydrophobic surface to DCs in much the same
manner as would apoptotic cells or endogenous stressors com-
pared to the more robust responses induced by microbial
PAMPs. Endogenous danger signals are known to stimulate a
robust adaptive immune response in the absence of deleterious
inﬂammatory responses,42 an attribute that would be valuable to
replicate when developing safe and eﬀective vaccines. Collec-
tively, these results indicate that polyanhydride nanoparticles can
be rationally functionalized to eﬀectively enhance activation of
APCs and lead to the design of eﬃcacious targeted vaccine
delivery platforms.
’CONCLUSIONS
In this study, novel “pathogen-like” particles were fabricated
by functionalizing the surface of polyanhydride nanoparticles
with sugar residues. The ability of these novel particles to induce
and enhance DC activation by speciﬁc interactions with the
mannose receptor was demonstrated. Targeting CLRs on DCs
with ligands covalently linked to polyanhydride nanoparticles
has the potential to eﬃciently deliver antigens toDCs for eﬀective
processing and presentation to T cells. A speciﬁc ligand
receptor interaction (i.e., dimannoseCD206) was identiﬁed by
blocking the mannose receptor on DCs, which resulted in the
inhibition of DC activation. This data indicates that mannose
receptor signaling pathways are involved in the expression of
surface molecules required for antigen presentation and T cell
costimulation. The receptor-mediated endocytosis induced by
the direct interaction of mannose residues with the mannose
receptor may be exploited to design eﬃcacious nanovaccines.
The initial interactions of these novel dimannose-functionalized
nanoparticles with CLRs on DCs have been demonstrated in
these studies; however, the biological consequences of these
interactions still need to be evaluated and are a continued area of
investigation in our laboratories.
’ASSOCIATED CONTENT
bS Supporting Information. Supplemental data on the eﬀect
of adding soluble sugars to cultures of DCs with nonfunctionalized
Figure 5. Mannose receptor-mediated activation of DCs by dimannose-functionalized nanoparticles is inhibited by receptor-speciﬁc monoclonal
antibodies. DC cultures were incubated for 15 min with either α-CD206, α-CD209 or α-CD206 + α-CD209, or medium (control, NS) and then were
stimulated with either nonfunctionalized (NF) or dimannose-functionalized nanoparticles for 48 h. DCs were harvested and analyzed via ﬂow cytometry
for changes in surface expression of (A) MHC II, (B) CD86, (C) CD40, (D) CIRE, or (E) CD206. MFI (mean ﬂuorescence intensity)( the SEM of
each of the markers of two independent experiments performed in triplicate is presented. * represents groups that are statistically signiﬁcant (pe 0.05)
compared to the control treatment.
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nanoparticles and the eﬀect of adding linker- and lactose-function-
alized nanoparticles to the cells that were treated with the blocking
antibodies. Thismaterial is available free of charge via the Internet at
http://pubs.acs.org.
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